Imunogenisitas, Keamanan, dan Efikasi Vaksin Malaria: Tinjauan Sistematis dan Network Meta-Analysis dari Uji Klinis Acak Terkontrol
Immunogenicity, safety, and efficacy of malarial vaccines: a systematic review and network meta-analysis of randomized controlled trials
DOI:
https://doi.org/10.58623/aspirator.v16i1.114Keywords:
vaksin malaria, imunogenisitas, keamanan, efikasi, network meta analysisAbstract
Malaria remains a major global health issue, with challenges in existing control methods like insecticide resistance and artemisinin-based therapy failures. Vaccines offer a promising solution to reduce transmission, build herd immunity, and decrease morbidity and mortality, especially in vulnerable populations. This study conducts a network meta-analysis of malaria vaccines to compare their immunogenicity, safety, and efficacy. A systematic review following PRISMA-NMA guidelines was performed using four databases—PubMed, Cochrane Library, ScienceDirect, and Google Scholar—assessing study quality with the Cochrane Risk of Bias 2.0 tool. The analysis, which included over 33,000 participants from 57 clinical trials, revealed that RTS,S/AS01 and RTS,S/AS02 significantly increased antibody titers despite heterogeneity. Safety outcomes showed RTS,S/AS02 and FMP1/AS02 were linked to increased injection site pain, and RTS,S vaccines had a higher risk of fever. R21/Matrix-M showed the highest efficacy in preventing clinical malaria episodes, though data on it were limited. Vaccines like PfSPZ and PvCS had fewer side effects but weaker antibody responses. Overall, RTS,S vaccines were highly immunogenic and effective, though safety profiles varied, and the limited data on certain vaccines like R21/Matrix-M underscored the need for further research to validate their long-term effects.
References
WHO. World malaria report 2023 [Internet]. 2023. 283 p. Available from: https://www.who.int/teams/global-malaria-programme/reports/world-malaria report-2023
Hadebe MT, Malgwi SA, Okpeku M. Revolutionizing Malaria Vector Control: The Importance of Accurate Species Identification through Enhanced Molecular Capacity. Microorganisms. 2024;12(1). DOI: https://doi.org/10.3390/microorganisms12010082
Keïta M, Sogoba N, Kané F, Traoré B, Zeukeng F, Coulibaly B, et al. Multiple Resistance Mechanisms to Pyrethroids Insecticides in Anopheles gambiae sensu lato Population from Mali, West Africa. J Infect Dis. 2021;223(Suppl 2):S81–90. DOI: https://doi.org/10.1093/infdis/jiaa190
Lindsay SW, Thomas MB, Kleinschmidt I. Threats to the effectiveness of insecticide-treated bednets for malaria control: thinking beyond insecticide resistance. Lancet Glob Heal [Internet]. 2021 Sep 1;9(9):e1325–31. Available from: https://pubmed.ncbi.nlm.nih.gov/34216565/ DOI: https://doi.org/10.1016/S2214-109X(21)00216-3
Pryce J, Medley N, Choi L. Indoor residual spraying for preventing malaria in communities using insecticide-treated nets. Cochrane Database Syst Rev [Internet]. 2022 Jan 17;2022(1). Available from: http://doi.wiley.com/10.1002/14651858.CD012688.pub3 DOI: https://doi.org/10.1002/14651858.CD012688.pub3
Duffy PE. Current approaches to malaria vaccines [Internet]. Vol. 70, Current Opinion in Microbiology. Elsevier Ltd; 2022. p. 102227. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC11127243/ DOI: https://doi.org/10.1016/j.mib.2022.102227
Kessy EJ, Olotu AI. Controlled human malaria infection: overview and potential application in the evaluation of transmission-blocking interventions in malaria-endemic areas. Malar J 2025 241 [Internet]. 2025 Feb 1;24(1):1–13. Available from: https://malariajournal.biomedcentral.com/articles/10.1186/ s12936-025-05277-x DOI: https://doi.org/10.1186/s12936-025-05277-x
Dicko A, Ouedraogo JB, Zongo I, Sagara I, Cairns M, Yerbanga RS, et al. Seasonal vaccination with RTS,S/AS01E vaccine with or without seasonal malaria chemoprevention in children up to the age of 5 years in Burkina Faso
and Mali: a double-blind, randomised, controlled, phase 3 trial. Lancet Infect Dis [Internet]. 2024 Jan 1;24(1):75–86. Available from: https://www.thelancet.com/action/showFullText?pii=S1473309923003687
Syed YY. RTS,S/AS01 malaria vaccine (Mosquirix®): a profile of its use. Drugs Ther Perspect Ration drug Sel use [Internet]. 2022 Sep 1;38(9):373–81. Available from: https://pubmed.ncbi.nlm.nih.gov/36093265/ DOI: https://doi.org/10.1007/s40267-022-00937-3
Review Manager (RevMan) [computer program]. The Cochrane Collaboration; 2020.
Papakonstantinou T, Nikolakopoulou A, Higgins JPT, Egger M, Salanti G. CINeMA: Software for semiautomated assessment of the confidence in the results of network meta-analysis. Campbell Syst Rev [Internet]. 2020 Mar 11;16(1). Available from: https://onlinelibrary.wiley.com/doi/10.1002/cl2.1080 DOI: https://doi.org/10.1002/cl2.1080
Nikolakopoulou A, Higgins JPT, Papakonstantinou T, Chaimani A, Del Giovane C, Egger M, et al. CINeMA: An approach for assessing confidence in the results of a network meta-analysis. PLOS Med [Internet]. 2020 Apr 3;17(4):e1003082. Available from: https://dx.plos.org/10.1371/journal.pmed.1003082 DOI: https://doi.org/10.1371/journal.pmed.1003082
Fitranda T, Bagus H, Dini, Agustina Vania R. Comparative efficacy, safety, and immunogenicity of malarial vaccines: a systematic review and meta-analysis of randomized controlled trials [Internet]. 2024 [cited 2024 May 16]. Available from: https://www.crd.york.ac.uk/PROSPERO/view/528994
Leroux-Roels G, Leroux-Roels I, Clement F, Ofori-Anyinam O, Lievens M, Jongert E, et al. Evaluation of the immune response to RTS,S/AS01 and RTS,S/AS02 adjuvanted vaccines: randomized, double-blind study in malaria-naïve
adults. Hum Vaccin Immunother [Internet]. 2014 Aug 1;10(8):2211–9. Available from: https://pubmed.ncbi.nlm.nih.gov/25424924/
Chutiyami M, Saravanakumar P, Bello UM, Salihu D, Adeleye K, Kolo MA, et al. Malaria vaccine efficacy, safety, and community perception in Africa: a scoping review of recent empirical studies. Infection [Internet]. 2024 Oct 1;52(5):2007–28. Available from: https://link.springer.com/article/10.1007/s15010-024-02196-y DOI: https://doi.org/10.1007/s15010-024-02196-y
Downloads
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Fitranda Taslim, Bagus Hermansyah, Dini Agustina, Vania Yuli
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution (CC-BY) 4.0 License that allows others to share the work with an acknowledgment of the work’s authorship and initial publication in this journal.
